HK joins global drug regulatory body ICH
Verified: 2 outlets have reported this story since Nov 20, 2 of them from Hong Kong.
Hong Kong has formally become a regulatory member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), a move the Health Bureau says marks a key step towards building the city into an international healthcare innovation hub. The ICH admitted Hong Kong, represented by the Pharmacy and Poisons Board, as its 20th regulatory member at its assembly in the Czech Republic on Tuesday. Other regulatory members include the National Medical Products Administration of China, as well as regulators from Europe, Switzerland, the UK and the US.…
⚠ A state-run outlet: it may reflect official government positions.
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
2 outlets from Hong Kong, where the story is: RTHK, South China Morning Post · how we count
- Nov 20, 5:20 AM UTCFirst report· you’re reading thisHK joins global drug regulatory body ICHnews.rthk.hk ↗
- Nov 20, 12:29 PM UTC+7 hHong Kong joins global drug body ahead of schedule, boosting regulatory ambitionsscmp.com ↗
- Verified: a second independent outlet reported itNov 20, 12:29 PM UTC · +7 h
No verification data yet
Checks run automatically as new sources are ingested.
Score bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
High · How we score this